New Therapeutic Agents Marketed in 2020: Part 1

New Therapeutic Agents Marketed in 2020: Part 1 is organized by American Pharmacists Association (APhA)

Initial release date: February 1, 2021
Expiration date: February 1, 2024 - No credit can be earned after this date

Target Audience: Pharmacists

Accreditation Information:
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours of CPE credit (0.10 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-124-H01-P.  

Description:
Following our review of each new therapeutic agent marketed in 2020, we compare the new drug with the older medication(s) with which it is most similar in properties and uses, and we identify advantages and disadvantages. Advantages and disadvantages are identified at the time the new drug is first marketed and do not reflect approval of additional new drugs and/or changes that occur after the drug is initially marketed.

Learning Objectives:
At the completion of this activity, the participant will be able to:

• Identify the new therapeutic agents and explain their appropriate use.
• Identify the indications and mechanisms of action of the new agents.
• Identify the most important adverse events and other risks of the new therapeutic agents.
• State the route of administration for each new drug and the most important considerations for dosage and administration.
• Compare the new therapeutic agents with older medications to which they are most similar
• in properties and/or use and identify the most important advantages and disadvantages of the new drugs.